Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Japanese
  • Korean
  • Chinese
Cover Image

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H1, 2015" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Alpha- Antitrypsin Deficiency 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Clinical Trials by G7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials 16
  • Clinical Trials by Phase 17
  • In Progress Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Unaccomplished Trials of Alpha- Antitrypsin Deficiency 21
  • Subjects Recruited Over a Period of Time 22
  • Clinical Trials by Sponsor Type 23
  • Prominent Sponsors 24
  • Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials 25
  • Prominent Drugs 26
  • Latest Clinical Trials News on Alpha- Antitrypsin Deficiency 27
  • Jan 07, 2015: Kamada Reports Encouraging Discussions with European Co-Rapporteurs Regarding European Filing for Inhaled Alpha-1 Antitrypsin to Treat AATD 27
  • Nov 18, 2014: Arrowhead Files For Regulatory Permission To Begin Phase 1 Trial Of RNAi Therapeutic ARC-AAT 27
  • Clinical Trial Profiles 28
  • Clinical Trial Overview of Top Companies 28
  • Grifols, S.A. 28
  • Clinical Trial Overview of Grifols, S.A. 28
  • Baxter International Inc. 29
  • Clinical Trial Overview of Baxter International Inc. 29
  • Kamada Ltd. 30
  • Clinical Trial Overview of Kamada Ltd. 30
  • CSL Limited 31
  • Clinical Trial Overview of CSL Limited 31
  • Applied Genetic Technologies Corporation 32
  • Clinical Trial Overview of Applied Genetic Technologies Corporation 32
  • F. Hoffmann-La Roche Ltd. 33
  • Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
  • Bayer AG 34
  • Clinical Trial Overview of Bayer AG 34
  • Arrowhead Research Corporation 35
  • Clinical Trial Overview of Arrowhead Research Corporation 35
  • Clinical Trial Overview of Top Institutes / Government 36
  • Hospices Civils de Lyon 36
  • Clinical Trial Overview of Hospices Civils de Lyon 36
  • University of Pittsburgh 37
  • Clinical Trial Overview of University of Pittsburgh 37
  • University of Massachusetts Worcester Campus 38
  • Clinical Trial Overview of University of Massachusetts Worcester Campus 38
  • Alpha-1 Foundation 39
  • Clinical Trial Overview of Alpha-1 Foundation 39
  • University of Massachusetts 40
  • Clinical Trial Overview of University of Massachusetts 40
  • Weill Cornell Medical College 41
  • Clinical Trial Overview of Weill Cornell Medical College 41
  • University of Miami 42
  • Clinical Trial Overview of University of Miami 42
  • University of Florida 43
  • Clinical Trial Overview of University of Florida 43
  • Five Key Clinical Profiles 44

Appendix 77

  • Abbreviations 77
  • Definitions 77
  • Research Methodology 78
  • Secondary Research 78
  • About GlobalData 79
  • Contact Us 79
  • Disclaimer 79
  • Source 79

List of Tables

List of Tables

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 17
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 21
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015* 28
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 29
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2015* 30
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015* 31
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Applied Genetic Technologies Corporation, 2015* 32
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 33
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Arrowhead Research Corporation, 2015* 35
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015* 36
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 37
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts Worcester Campus, 2015* 38
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Alpha-1 Foundation, 2015* 39
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2015* 40
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 41
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015* 42
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 43

List of Figures

List of Figures

  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
  • Alpha- Antitrypsin Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
  • Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 16
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
  • Alpha- Antitrypsin Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
  • GlobalData Methodology 78
Show More
Pricing
Back to Top